Molecular Devices and STEMCELL Technologies Collaborate on Organoid Model Automation

Molecular Devices and STEMCELL Technologies have announced a collaboration aimed at speeding up the uptake of human-relevant organoid models by utilizing automation. The new workflow integrates organoid biology expertise with laboratory automation.

The workflow has been validated on the CellXpress.ai® Automated Cell Culture System. The objective is to assist researchers in reducing variability and scaling their research more effectively. This is expected to increase confidence in moving discoveries toward practical impact.

The collaboration is anticipated to significantly enhance the reproducibility and scalability of organoid research. These models are crucial for drug development and understanding diseases, as they more closely mimic human tissues than traditional cell cultures.

By combining Molecular Devices' automation solutions with STEMCELL Technologies' organoid culture expertise, the companies aim to lower the barrier for utilizing organoid technology to accelerate the discovery of new therapeutic solutions.